FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Alder BioPharmaceuticals (NASDAQ: ALDR) reported Q1 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Alder BioPharmaceuticals (ALDR) click here.
... More

